Verve Therapeutics Inc (VERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 32,976 | 13,080 | 6,865 | 6,692 | 5,695 |
| Gross Profit | 32,976 | 13,080 | 6,865 | 6,692 | 5,695 |
| Operating Expenses | 69,612 | 69,147 | 63,775 | 65,531 | 62,539 |
| Operating Income | -36,636 | -56,067 | -56,910 | -58,839 | -56,844 |
| Other Income | 5,682 | 6,105 | 6,881 | 9,100 | 8,214 |
| Pre-tax Income | -30,954 | -49,962 | -50,029 | -49,739 | -48,630 |
| Income Tax | 79 | 73 | 104 | 66 | 106 |
| Net Income Continuous | -31,033 | -50,035 | -50,133 | -49,805 | -48,736 |
| Net Income | $-31,033 | $-50,035 | $-50,133 | $-49,805 | $-48,736 |
| EPS Basic Total Ops | -0.35 | -0.58 | -0.59 | -0.59 | -0.59 |
| EPS Basic Continuous Ops | -0.35 | -0.58 | -0.59 | -0.59 | -0.59 |
| EPS Diluted Total Ops | -0.35 | -0.58 | -0.59 | -0.59 | -0.59 |
| EPS Diluted Continuous Ops | -0.35 | -0.58 | -0.59 | -0.59 | -0.59 |
| EPS Diluted Before Non-Recurring Items | -0.35 | -0.58 | -0.59 | -0.59 | -0.59 |
| EBITDA(a) | $-36,813 | $-56,522 | $-57,901 | $-60,710 | $-59,179 |